Lamez 25 Tablet DT contains Lamotrigine 25 mg, an anticonvulsant medication primarily indicated for the management of epilepsy and bipolar disorder. Lamotrigine acts by stabilizing neuronal membranes through the inhibition of voltage-sensitive sodium channels, thereby modulating the release of excitatory neurotransmitters such as glutamate and aspartate. This mechanism helps in reducing the frequency and severity of seizures in patients with partial seizures, generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome. Additionally, Lamotrigine is effective as a mood stabilizer in the maintenance treatment of bipolar disorder, particularly in preventing depressive episodes. Lamez 25 Tablet DT is designed for orodispersible administration, facilitating ease of use and rapid onset of action, which is beneficial for patients with swallowing difficulties. The dosage should be individualized based on clinical response and tolerability, with gradual titration recommended to minimize the risk of serious skin reactions such as Stevens-Johnson syndrome. Common adverse effects include dizziness, headache, blurred vision, and nausea. Lamez 25 Tablet DT should be used under strict medical supervision, with regular monitoring for hypersensitivity reactions and other potential side effects. It is contraindicated in patients with known hypersensitivity to Lamotrigine or any excipients.